Skip to content
PICO Portalanswers from OpenAlex

Autophagy inhibition by targeting PIKfyve potentiates response to immune checkpoint blockade in prostate cancer

PaperCitations, authors & open-access status

Autophagy inhibition by targeting PIKfyve potentiates response to immune checkpoint blockade in prostate cancer is a paper indexed in PICO Portal from OpenAlex.

How many citations does Autophagy inhibition by targeting PIKfyve potentiates response to immune checkpoint blockade in prostate cancer have?

PICO Portalcitation count

Autophagy inhibition by targeting PIKfyve potentiates response to immune checkpoint blockade in prostate cancer has 107 citations in the OpenAlex counts PICO Portal stores.

When was Autophagy inhibition by targeting PIKfyve potentiates response to immune checkpoint blockade in prostate cancer published?

PICO Portalyear

Autophagy inhibition by targeting PIKfyve potentiates response to immune checkpoint blockade in prostate cancer has 2021 year in the PICO Portal index.

What is the open-access status of Autophagy inhibition by targeting PIKfyve potentiates response to immune checkpoint blockade in prostate cancer?

PICO Portaloa status

Autophagy inhibition by targeting PIKfyve potentiates response to immune checkpoint blockade in prostate cancer has green oa status in the PICO Portal index.

What is the DOI of Autophagy inhibition by targeting PIKfyve potentiates response to immune checkpoint blockade in prostate cancer?

PICO Portaldoi

The DOI for Autophagy inhibition by targeting PIKfyve potentiates response to immune checkpoint blockade in prostate cancer is on the source record.

What is the PMID of Autophagy inhibition by targeting PIKfyve potentiates response to immune checkpoint blockade in prostate cancer?

PICO Portalpmid

The PMID for Autophagy inhibition by targeting PIKfyve potentiates response to immune checkpoint blockade in prostate cancer is on the source record.

What is the OpenAlex record for Autophagy inhibition by targeting PIKfyve potentiates response to immune checkpoint blockade in prostate cancer?

PICO Portalopenalex

The OpenAlex for Autophagy inhibition by targeting PIKfyve potentiates response to immune checkpoint blockade in prostate cancer is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial